HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
Patient Power: How Aggressive Should Smoldering Myeloma Treatment Be?
Posted: Jan 30, 2019
Patient Power: How Aggressive Should Smoldering Myeloma Treatment Be? image

Because smoldering myeloma isn't quite active myeloma, a question remains of which treatment approach is best for a smoldering patient. In a recent interview with Patient Power, Dr. Carol Ann Huff, Dr. Suzanne Lentzsch, Dr. Sagar Lonial and Jennifer Ahlstrom of the Myeloma Crowd addressed this topic.

Treating patients earlier before they develop organ damage, anemia, or hypercalcemia would be ideal for smoldering myeloma. However, there are still studies underway addressing exactly how aggressive a treatment should be. Smoldering patients can continue being smoldering for a long period of time without the side effects of an early therapy treatment, noted Dr. Lonial.

"I think we’re all very much in favor, if we are able to treat patients prior to them becoming symptomatic and improving their longevity, as well as their quality of life, we’re all supportive of that." --Dr. Huff

As of yet, there is no standard of care for smoldering myeloma patients. Each situation needs to be addressed individually. 

Dr. Lentzsch concluded, "...patients have to be careful not to make the mistake to say, 'Oh, I have smoldering myeloma, and I need treatment right away.' I think the question needs to be answered in randomized trials."

 

How Aggressive Should Smoldering Myeloma Treatment Be? from Patient Power on Vimeo.

 

The author Erika Johnson

about the author
Erika Johnson

Myeloma Crowd Editorial Contributor, Nursing student, and cancer advocate.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Amgen Oncology
Abbvie
Genentech
GSK
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube